A case-control study included 67 PD patients compared to 24 healthy controls and exhibited that plasma levels of α-synuclein, NLRP3 inflammasome, caspase-1, and IL-1β were increased in PD patients compared to healthy controls [132]. This evidence concerns the gene IL1B and Parkinson disease.